Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.08M | -39.88M | -38.65M | -38.43M | -38.02M |
| Total Depreciation and Amortization | 1.01M | 982.20K | 971.60K | 938.00K | 899.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.81M | 3.28M | 2.82M | 3.17M | 3.51M |
| Change in Net Operating Assets | -1.68M | -606.60K | 489.90K | 1.52M | 2.59M |
| Cash from Operations | -38.94M | -36.23M | -34.36M | -32.80M | -31.03M |
| Capital Expenditure | -379.30K | -266.20K | -162.40K | -167.90K | -172.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.12M | 4.08M | 12.90K | 9.48M | 18.97M |
| Cash from Investing | 7.74M | 3.82M | -149.60K | 9.31M | 18.80M |
| Total Debt Issued | 14.12M | 14.12M | 14.12M | 7.19M | 255.00K |
| Total Debt Repaid | -15.83M | -15.82M | -15.82M | -8.17M | -520.00K |
| Issuance of Common Stock | 50.08M | 60.04M | 70.00M | 45.00M | 20.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.69M | -4.71M | -5.74M | -3.90M | -2.05M |
| Cash from Financing | 48.38M | 58.00M | 67.70M | 43.78M | 19.11M |
| Foreign Exchange rate Adjustments | 340.60K | -33.30K | -403.00K | -518.40K | -636.80K |
| Miscellaneous Cash Flow Adjustments | 1.10K | 1.10K | 1.10K | 1.10K | 1.00K |
| Net Change in Cash | 17.52M | 25.56M | 32.79M | 19.78M | 6.25M |